IRCT20240304061158N4招募中1 期
A Clinical trial to evaluate the safety and immunomodulatory efficacy of Byolic CC supplement compared to placebo in healthy adults
Behpad Teb Iranian0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 60 years（—）
- 性别
- All
入选标准
- •Health of volunteers
排除标准
- •usage of immunosuppressive drugs, including cytotoxic drugs and corticosteroids, or any other drug (within 4 weeks before the start of the study) that may interfere with the supplement used in this study (or other herbal products)
- •drug and food allergies
- •pregnancy and lactation
- •cardiovascular, kidney, lung, liver, endocrine, hematological, neurological or psychiatric diseases, etc.)
研究者
相似试验
已完成
不适用
Phase I clinical trial to assess safety and immunogenicity of an MVA-based influenza H5 vaccine in healthy adultsflu10047438InfluenzaNL-OMON38408Erasmus MC, Universitair Medisch Centrum Rotterdam27
招募中
3 期
Clinical Trial of quadrivalent Papilloguard4 vaccine (Human Papillomavirus Types 6, 11, 16, 18) manufactured by Nivad Pharmed Salamat in comparison with GardasilGenital wart prevention.Anogenital (venereal) wartsA63.0IRCT20240120060741N1ivad Pharmed Salamat670
已完成
1 期
A Phase I clinical trial to assess safety and immune response of Influenza vaccine of Serum Institute of India Limited in Adults.CTRI/2011/09/002033Serum Institute of India Ltd Pune India40
招募中
3 期
A comparison of safety and immunogenicity between government of India approved Rabies pre exposure prophylaxis regimen and WHO Rabies pre exposure prophylaxis regimeCTRI/2023/09/057399Dr N R Ramesh Masthi
进行中（未招募）
1 期
Safety and immunogenicity of RNA-based vaccines against SARS-CoV-2 variants in healthy participantsProtection against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2).MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 23.0Level: HLTClassification code 10084510Term: Coronavirus infectionsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 23.1Level: LLTClassification code 10084529Term: 2019 novel coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2021-003458-22-DEBioNTech SE1,470